DRIM inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the DRIM protein, which likely stands for a domain related to intracellular motility or some specific molecular process in cellular dynamics. DRIM, based on its name, may be involved in regulating the movement of intracellular components, contributing to processes such as vesicle transport, cytoskeletal dynamics, or signal transduction. Proteins involved in intracellular motility are crucial for ensuring the proper localization of cellular organelles, vesicles, and proteins, thus playing a key role in maintaining cellular organization and function. By inhibiting DRIM, researchers can explore its specific role in these intracellular processes, potentially shedding light on how it influences transport mechanisms or cytoskeletal rearrangements.
The mechanism of DRIM inhibitors typically involves binding to functional domains of the DRIM protein that are essential for its role in intracellular motility. These inhibitors may block DRIM's interaction with motor proteins, cytoskeletal elements, or other binding partners necessary for its activity. Structurally, DRIM inhibitors are often designed to mimic the protein's natural ligands or interact with key binding sites to prevent proper functioning. This disruption could lead to altered intracellular transport, impaired organelle movement, or changes in cell shape and migration. By studying DRIM inhibitors, researchers can gain valuable insights into the molecular mechanisms of intracellular motility and how specific proteins like DRIM contribute to maintaining the spatial organization and transport dynamics of various cellular components. This knowledge enhances understanding of the broader regulatory networks involved in intracellular movement and cellular architecture.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Known to inhibit PI3K, a crucial kinase in several signaling pathways. By inhibiting PI3K, downstream signaling events can be affected. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor which can disrupt downstream signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, part of the MAPK/ERK pathway. Its inhibition can disrupt several cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Targets p38 MAP kinase, potentially affecting signaling pathways where p38 is involved. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can disrupt AP-1 mediated transcription among other processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum kinase inhibitor which can affect multiple pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, potentially affecting various cellular signaling pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB pathway inhibitor. This can affect various cellular processes regulated by NF-κB. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $133.00 | 12 | |
Specifically inhibits IKK-2, thereby affecting the NF-κB pathway. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Intracellular calcium chelator, affecting calcium signaling pathways. | ||||||